DVA Share Price Performance
US$120.25
-45.26 (-27.35%)
18.3% undervalued intrinsic discount
US$147.13
Fair Value
Price US$120.25
AnalystConsensusTarget US$147.13
Fair ValueUS$144.50
Share Pricen/a
DaVita Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 41 Fair Values set on narratives written by author
DVA Community Narratives
AN
Fair Value US$144.5 n/aintrinsic discount
DVA: Policy Shifts And Operational Recovery Will Shape Outlook In 2025
1users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
DVA: Policy Shifts And Operational Recovery Will Shape Outlook In 2025
Key Takeaways Structural cost reductions and clinical innovation are improving operational efficiency, patient outcomes, and margins, mitigating risk from volume fluctuations. Strategic international expansion is driving diversified growth and presents opportunities for further revenue and margin gains.Read more
1users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
AN
US$144.5
n/aintrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
4.45% p.a.
Profit Margin
6.25%
Future PE
10.75x
Share price in 2028
US$179.56
Recently Updated Narratives
AN
DVA: Policy Shifts And Operational Recovery Will Shape Outlook In 2025
Fair Value: US$144.5 0% overvalued intrinsic discount
19 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
DaVita Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- 10.93
- 31.98%
- 5.80%
- 749.8%
About DVA
- Founded
- 1994
- Employees
- 76000
- CEO
- WebsiteView website
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
